ABBV Competitors & Alternatives
Compare AbbVie Inc with similar stocks in the same industry
Drug Manufacturers - General
ABBV
Main Stock$250.94
Tradestie Score
52
Market Cap
$431.71B
P/E Ratio
130.0
Revenue Growth
0.1%
Analyst Upside
+7.1%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$1148.84
|
$739.95B | 42.9 | 49 | Compare |
|
JNJ
Johnson & Johnson
|
$256.35
|
$448.07B | 30.8 | 53 | Compare |
|
NVO
Novo-Nordisk A/S
|
$47.08
|
$262.92B | 12.4 | 39 | Compare |
|
AZN
AstraZeneca PLC
|
$169.64
|
$261.56B | 26.0 | 56 | Compare |
|
NVS
Novartis AG
|
$156.15
|
$254.99B | 24.0 | 56 | Compare |
|
ABT
Abbott Laboratories
|
$105.70
|
$232.30B | 35.0 | 52 | Compare |
|
MRK
Merck & Co., Inc.
|
$130.20
|
$225.13B | 36.8 | 56 | Compare |
|
AMGN
Amgen Inc
|
$385.16
|
$160.70B | 27.0 | 56 | Compare |
|
PFE
Pfizer Inc.
|
$25.01
|
$154.70B | 19.0 | 56 | Compare |
|
GILD
Gilead Sciences Inc
|
$130.21
|
$137.92B | 18.1 | 54 | Compare |
More ABBV Analysis
Data updated: Aug 03, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry